Balyasny Asset Management’s Verona Pharma VRNA Stock Holding History

Balyasny Asset Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-48,500	Closed	-$2.25M	–	3325
2024 Q4	$2.25M	Buy	+48,500	New	+$1.82M	﹤0.01%	1629

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Balyasny Asset Management's VRNA Position: Q4 2025 in Review

Balyasny Asset Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 1,863,426 shares — an estimated $199M sold.

Balyasny Asset Management first reported a position in VRNA in Q3 2023 and held it in 5 quarters. The position peaked at $199M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Balyasny Asset Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Balyasny Asset Management sold 1,863,426 Verona Pharma shares in Q4 2025, an estimated $199M.
Balyasny Asset Management first reported a position in Verona Pharma in Q3 2023 and held it in 5 quarters.
Balyasny Asset Management's Verona Pharma position peaked at $199M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.